Xiaoyue He

ORCID: 0000-0003-3582-4539
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ubiquitin and proteasome pathways
  • Cancer, Hypoxia, and Metabolism
  • RNA modifications and cancer
  • Cancer, Lipids, and Metabolism
  • Peptidase Inhibition and Analysis
  • Mycobacterium research and diagnosis
  • Fungal Infections and Studies
  • melanin and skin pigmentation
  • Antimicrobial Peptides and Activities
  • Autoimmune and Inflammatory Disorders
  • Cancer-related gene regulation
  • Prostate Cancer Treatment and Research
  • Glycosylation and Glycoproteins Research
  • Actinomycetales infections and treatment
  • Diet and metabolism studies

Guangzhou Medical University
2021-2024

First Affiliated Hospital of GuangXi Medical University
2018-2020

Guangxi Medical University
2018-2020

Abstract Background Hepatocellular carcinoma (HCC) remains a medical challenge due to its high proliferation and metastasis. Although deubiquitinating enzymes (DUBs) play key role in regulating protein degradation, their pathological roles HCC have not been fully elucidated. Methods By using biomass spectrometry, co-immunoprecipitation, western blotting immunofluorescence assays, we identify ribosomal S16 (RPS16) as substrate of ubiquitin-specific peptidase 1 (USP1). The USP1-RPS16 axis the...

10.1186/s13046-021-02008-3 article EN cc-by Journal of Experimental & Clinical Cancer Research 2021-06-21

Abstract Androgen receptor splice variant 7 (AR-V7), a form of ligand-independent and constitutively activating androgen (AR), is considered as the key driver to initiate castration-resistant prostate cancer (CRPC). Because AR-V7 lacks ligand-binding domain, AR-targeted therapies that aim inactivate AR signaling through disrupting interaction between are limited in CRPC. Thus, emergence has become greatest challenge for treating Targeting protein degradation recently proposed novel avenue...

10.1038/s41419-021-04162-0 article EN cc-by Cell Death and Disease 2021-09-21

HER2 is a transmembrane receptor with intrinsic tyrosine kinase activity that overexpressed in almost 25% of human breast cancers. Here, we report the neddylation new post-translational modification controls its expression and oncogenic cancer. Two critical members pathway, NEDD8 NEDD8-activating enzyme E1 subunit 1 (NAE1), are detected specimens. Overexpressed NAE1 positively correlated Subsequent structure function experiments show directly interacts NAE1, whereas protein decreased by...

10.7150/ijbs.75852 article EN cc-by-nc International Journal of Biological Sciences 2022-12-19
Coming Soon ...